United States
Germany
Japan
United Kingdom
China
CA 19-9 human protein, 250 kU
| Protein Source | Human metastatic liver carcinoma |
Native Proteins
Cyfra-21-1 human protein, 50 µg
| Protein Source | Cell culture |
Human IgE (kappa + lambda chain) human protein, 0.1 mg
| Protein Source | Myeloma |
LDH4 human protein, 0.1 kU
| Protein Source | Liver |
LDH2 human protein, 0.1 kU
| Protein Source | Erythrocytes |
Human HDL 2 Subfraction human protein, 1 mg
| Protein Source | Plasma |
Hemoglobin human protein, 2 g
| Protein Source | Erythrocytes |
Human IgA1 Kappa Kappa human protein, 5 mg
| Protein Source | Myeloma |
CA 19-9 human protein, 50 kU
| Protein Source | Cell culture |
Human IgA human protein, 1 mg
| Protein Source | Plasma |
Glycohemoglobin / HBA1c human protein, 1 mg
| Protein Source | Erythrocytes |
D-Dimer human protein, 0.2 mg
| Protein Source | Plasma |
Human IgA (secretory) human protein, 5 mg
| Protein Source | Milk |
Fibrinogen (plasmin + plasminogen free) human protein, 25 mg
| Protein Source | Serum |
Laminin human protein, 0.1 mg
| Protein Source | Placenta |
